4basebio PLC (AIM:4BB)
525.00
0.00 (0.00%)
Jul 6, 2026, 8:00 AM GMT
4basebio Revenue
In the year 2025, 4basebio had annual revenue of 1.69M GBP with 81.46% growth. 4basebio had revenue of 519.00K in the half year ending December 31, 2025, with 93.66% growth.
Revenue
1.69M
Revenue Growth
+81.46%
P/S Ratio
48.19
Revenue / Employee
12.09K
Employees
140
Market Cap
81.58M
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.69M | 760.00K | 81.46% |
| Dec 31, 2024 | 933.00K | 427.00K | 84.39% |
| Dec 31, 2023 | 506.00K | 238.00K | 88.81% |
| Dec 31, 2022 | 268.00K | -70.00K | -20.71% |
| Dec 31, 2021 | 338.00K | -124.00K | -26.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| hVIVO | 49.66M |
| Bioventix | 12.54M |
| SkinBioTherapeutics | 5.23M |
| Scancell Holdings | 4.71M |
| PureTech Health | 3.46M |
| Arecor Therapeutics | 1.71M |
| Ondine Biomedical | 1.43M |
| Faron Pharmaceuticals Oy | 1.14M |
4basebio News
- 6 days ago - 4basebio Plc - Result of AGM & Issue of Options - Finanz Nachrichten
- 20 days ago - 4basebio Plc - Notice of Investor Presentation - Finanz Nachrichten
- 21 days ago - 4basebio Plc - 4basebio Appoints Dr. Jeff Coller to Strategic Advisory Board - Finanz Nachrichten
- 4 weeks ago - 4basebio Plc - Notice of Annual General Meeting - Finanz Nachrichten
- 6 weeks ago - 4basebio Plc - Director Dealing - Finanz Nachrichten
- 6 weeks ago - 4basebio Plc - 4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial - Finanz Nachrichten
- 7 weeks ago - 4basebio Names Richard Bungay CFO; Announces Board Changes - Nasdaq
- 7 weeks ago - 4basebio Announces Appointment of Chief Financial Officer and Board Changes - Wallstreet:Online